8-K 1 eight-k_june23.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934

Date of report (date of earliest event reported): June 23, 2003


	ALARIS MEDICAL, INC.

(Exact name of registrant as specified in its charter)
Delaware	1-10207	13-3492624

(State or other jurisdiction of	(Commission File Number)	(I.R.S. Employer
incorporation or organization)		Identification Number)

	10221 Wateridge Circle San Diego, CA 92121-1579

(Address, including zip code, of registrant’s principal executive offices)

	(858) 458-7000

Registrant’s telephone number, including area code

Page 1 of 5

Item 5. Other Disclosure

On June 23, 2003, ALARIS Medical, Inc. and its wholly-owned subsidiary, ALARIS Medical Systems, Inc., announced today that the companies have extended the expiration date of their cash tender offers. The press release is attached as Exhibit 99.1.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



		ALARIS MEDICAL, INC.

Date: June 23, 2003

/s/DAVID L. SCHLOTTERBECK
————————————————
David L. Schlotterbeck
President and Chief Executive Officer

EXHIBIT INDEX

Exhibit